Viatris Pacira Deal: $1.65 Billion Bet on Non-Opioid Pain Relief
Viatris will buy Pacira BioSciences for $36.50 a share in cash, about $1.65 billion, in a bet on non-opioid pain drugs. Here is how the deal…
Health
FDA May Ease Restrictions on Peptides: What It Means for the Exploding Wellness Trend
The wellness world might be on the verge of a major shift—and it’s coming straight from Washington. The U.S. Food and Drug Administration (FDA) is preparing to review whether to loosen restrictions…
Local weather
Finding your area…National Weather Service
Trending
- College Football Week 6 Guide: Georgia-Alabama, Red River and Every Big Game to Watch
- College Football Playoff Expansion: ESPN Talks Roll On Past Deadline
- Georgia Beats Alabama 20-17 as Hurricane Isaias Soaks Tuscaloosa
- Starbucks Chipotle Takeover Report: Coffee Giant Wouldn’t Say No
- What the La Liga Suspension Means for Rayo and Athletic